Newsletter | September 2, 2026

09.02.26 -- Unlocking Hidden U.S. Supply Chain Capacity

SPONSOR

 

 

Mikart’s 50 years of experience as a CDMO in oral solid and nonsterile oral liquid dosage forms, combined with our specialization in pediatric, geriatric, and controlled-substance products, make us an ideal partner from formulation development through commercialization. We prioritize long-lasting relationships and a personalized, hands-on approach — delivering the reliability, technical expertise, and flexibility needed to meet your goals, navigate complexity, and consistently exceed expectations at every stage. Click here to learn more.

INDUSTRY INSIGHTS

 

The Art And Science Of Getting Tech Transfer Right First Time

Technology transfer connects drug development to scalable manufacturing through early engagement, open knowledge sharing, and data-driven methods like Design of Experiments to advance therapies.

 

Secondary Packaging: Cartoning And Kitting With An Aggressive Timeline

Meeting tight launch timelines requires more than speed. Smart kit design, controlled production workflows, and scalable processes come together to deliver complex packaging programs quickly.

 

Integrate Ops And Supply Chain To Ensure Consistent Drug Availability

To ensure consistent drug supply, pharmaceutical companies must integrate operations and supply chain management for proactive planning and global risk mitigation.

FEATURED EDITORIAL

Unlocking Hidden U.S. Supply Chain Capacity

The search for supply chain partners goes on. Intensely. But productively? Are we missing anything? We are about to learn the answer to that is yes.  Alan Davis, President & CEO, i5 Services says puzzling is how little these searches vary – and he's concerned that invariance has negative national supply-chain implications. He has a mission and a search platform to change that.

 

Rebuilding America's Pharmaceutical Backbone Through Small-Batch Manufacturing

Many small molecule products no longer require massive production. Instead, flexible capacity is needed that can economically produce smaller commercial volumes while maintaining quality and compliance.

INDUSTRY INSIGHTS CONTINUED

 

Replacing Functional Handoffs With Project-Based Execution

Learn how positive compliance experiences can support operational excellence, reduce risk, and strengthen manufacturing performance.

 

5 Must-Haves From Your Peptide Building Block Supplier

Whether you are just entering the peptide market or scaling an established product, access to a reliable supply of high-quality building blocks is critical to running a successful peptide program.

 

An Industry Approach To Adsorb Lipids Onto Powder Substrates

Explore innovative solutions for improving the solubility and bioavailability of poorly soluble compounds in solid oral dosage forms to enhance drug delivery and therapeutic effectiveness.

 

Pharmaceutical Spray Drying: Sustainable Commercial Best Practices

Watch more about defining the spray drying process with an emphasis on specific enhancements to accommodate scale-up to commercial scale equipment of challenging applications or molecules.

SOLUTIONS

OSD Capabilities Overview

Oral Solid Dose Manufacturing From Development To Commercial Supply

Testosterone API Catalog

Maximize Uptime And Yield With This Feeder Base Leveling System

OUTSOURCED PHARMA CAPABILITIES UPDATE

Find Your New CDMO At Outsourced Pharma Capabilities Update

CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs.

 

Connect With Outsourced Pharma: